A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand

NCT00370682 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

FED

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: T-DEN F17
BIOLOGICAL: T-DEN F-19
OTHER: Placebo Comparator

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]